Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1986 Sep;68:27–32. doi: 10.1289/ehp.866827

SENCAR mouse skin tumorigenesis model versus other strains and stocks of mice.

T J Slaga
PMCID: PMC1474258  PMID: 3096709

Abstract

The SENCAR mouse stock was selectively bred for eight generations for sensitivity to skin tumor induction by the two-stage tumorigenesis protocol using 7,12-dimethylbenz(a)anthracene (DMBA) as the initiator and 12-O-tetradecanoylphorbol-13-acetate (TPA) as the promoter. The SENCAR mouse was derived by crossing Charles River CD-1 mice with skin-tumor-sensitive mice (STS). The SENCAR mice are much more sensitive to both DMBA tumor initiation and TPA tumor promotion than CD-1, BALB/c, and DBA/2 mice. An even greater difference in the sensitivity to two-stage skin tumorigenesis is apparent between SENCAR and C57BL/6 mice when using DMBA-TPA treatment. However, the SENCAR and C57BL/6 mice have a similar tumor response to DMBA-benzoyl peroxide treatment, suggesting that TPA is not an effective promoter in C57BL/6 mice. The DBA/2 mice respond in a similar manner to the SENCAR mice when using N-methyl-N-nitro-N-nitrosoguanidine (MNNG)-TPA treatment. The SENCAR mouse model provides a good dose-response relationship for many carcinogens used as tumor initiators and for many compounds used as tumor promoter. When compared to other stocks and strains of mice, the SENCAR mouse has one of the largest data bases for carcinogens and promoters.

Full text

PDF
29

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOUTWELL R. K. SOME BIOLOGICAL ASPECTS OF SKIN CARCINOGENISIS. Prog Exp Tumor Res. 1964;4:207–250. doi: 10.1159/000385978. [DOI] [PubMed] [Google Scholar]
  2. Buhler D. R., Unlu F., Thakker D. R., Slaga T. J., Newman M. S., Levin W., Conney A. H., Jerina D. M. Metabolism and tumorigenicity of 7-, 8-, 9-, and 10-fluorobenzo(a)pyrenes. Cancer Res. 1982 Nov;42(11):4779–4783. [PubMed] [Google Scholar]
  3. DiGiovanni J., Diamond L., Singer J. M., Daniel F. B., Witiak D. T., Slaga T. J. Tumor-initiating activity of 4-fluoro-7,12-dimethylbenz[a]anthracene and 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene in female SENCAR mice. Carcinogenesis. 1982;3(6):651–655. doi: 10.1093/carcin/3.6.651. [DOI] [PubMed] [Google Scholar]
  4. DiGiovanni J., Rymer J., Slaga T. J., Boutwell R. K. Anticarcinogenic and cocarcinogenic effects of benzo[e]pyrene and dibenz[a,c]anthracene on skin tumor initiation by polycyclic hydrocarbons. Carcinogenesis. 1982;3(4):371–375. doi: 10.1093/carcin/3.4.371. [DOI] [PubMed] [Google Scholar]
  5. DiGiovanni J., Slaga T. J., Boutwell R. K. Comparison of the tumor-initiating activity of 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene in female SENCAR and CS-1 mice. Carcinogenesis. 1980 May;1(5):381–389. doi: 10.1093/carcin/1.5.381. [DOI] [PubMed] [Google Scholar]
  6. Hennings H., Devor D., Wenk M. L., Slaga T. J., Former B., Colburn N. H., Bowden G. T., Elgjo K., Yuspa S. H. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Cancer Res. 1981 Mar;41(3):773–779. [PubMed] [Google Scholar]
  7. Huberman E., Slaga T. J. Mutagenicity and tumor-initiating activity of fluorinated derivatives of 7,12-dimethylbenz(a)anthracene. Cancer Res. 1979 Feb;39(2 Pt 1):411–414. [PubMed] [Google Scholar]
  8. Iyer R. P., Lyga J. W., Secrist J. A., 3rd, Daub G. H., Slaga T. J. Comparative tumor-initiating activity of methylated benzo(a)pyrene derivatives in mouse skin. Cancer Res. 1980 Apr;40(4):1073–1076. [PubMed] [Google Scholar]
  9. Levin W., Buening M. K., Wood A. W., Chang R. L., Kedzierski B., Thakker D. R., Boyd D. R., Gadaginamath G. S., Armstrong R. N., Yagi H. An enantiomeric interaction in the metabolism and tumorigenicity of (+)- and (-)-benzo[a]pyrene 7,8-oxide. J Biol Chem. 1980 Oct 10;255(19):9067–9074. [PubMed] [Google Scholar]
  10. Nesnow S., Triplett L. L., Slaga T. J. Comparative tumor-initiating activity of complex mixtures from environmental particulate emissions on SENCAR mouse skin. J Natl Cancer Inst. 1982 May;68(5):829–834. [PubMed] [Google Scholar]
  11. Nesnow S., Triplett L. L., Slaga T. J. Mouse skin tumor initiation-promotion and complete carcinogenesis bioassays: mechanisms and biological activities of emission samples. Environ Health Perspect. 1983 Jan;47:255–268. doi: 10.1289/ehp.8347255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Raveh D., Slaga T. J., Huberman E. Cell-mediated mutagenesis and tumor-initiating activity of the ubiquitous polycyclic hydrocarbon, cyclopenta[c,d]pyrene. Carcinogenesis. 1982;3(7):763–766. doi: 10.1093/carcin/3.7.763. [DOI] [PubMed] [Google Scholar]
  13. Reiners J. J., Jr, Nesnow S., Slaga T. J. Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion. Carcinogenesis. 1984 Mar;5(3):301–307. doi: 10.1093/carcin/5.3.301. [DOI] [PubMed] [Google Scholar]
  14. Slaga T. J., Bracken W. J., Gleason G., Levin W., Yagi H., Jerina D. M., Conney A. H. Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo(a)pyrene 7,8-diol-9,10-epoxides. Cancer Res. 1979 Jan;39(1):67–71. [PubMed] [Google Scholar]
  15. Slaga T. J., Bracken W. M., Dresner S., Levin W., Yagi H., Jerina D. M., Conney A. H. Skin tumor-initiating activities of the twelve isomeric phenols of benzo(a)pyrene. Cancer Res. 1978 Mar;38(3):678–681. [PubMed] [Google Scholar]
  16. Slaga T. J., Bracken W. M., Viaje A., Berry D. L., Fischer S. M., Miller D. R. Lack of involvement of 6-hydroxymethylation in benzo[a]pyrene skin tumor initiation in mice. J Natl Cancer Inst. 1978 Aug;61(2):451–455. [PubMed] [Google Scholar]
  17. Slaga T. J., Fischer S. M. Strain differences and solvent effects in mouse skin carcinogenesis experiments using carcinogens, tumor initiators and promoters. Prog Exp Tumor Res. 1983;26:85–109. doi: 10.1159/000407254. [DOI] [PubMed] [Google Scholar]
  18. Slaga T. J., Fischer S. M., Weeks C. E., Klein-Szanto A. J., Reiners J. Studies on the mechanisms involved in multistage carcinogenesis in mouse skin. J Cell Biochem. 1982;18(1):99–119. doi: 10.1002/jcb.1982.240180109. [DOI] [PubMed] [Google Scholar]
  19. Slaga T. J., Gleason G. L., DiGiovanni J., Sukumaran K. B., Harvey R. G. Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin. Cancer Res. 1979 Jun;39(6 Pt 1):1934–1936. [PubMed] [Google Scholar]
  20. Slaga T. J., Gleason G. L., Hardin L. Comparison of the skin tumor initiating activity of 3-methylcholanthrene and 3,11-dimethylcholanthrene in mice. Cancer Lett. 1979 Jul;7(2-3):97–102. doi: 10.1016/s0304-3835(79)80102-0. [DOI] [PubMed] [Google Scholar]
  21. Slaga T. J., Gleason G. L., Mills G., Ewald L., Fu P. P., Lee H. M., Harvey R. G. Comparison of the skin tumor-initiating activities of dihydrodiols and diol-epoxides of various polycyclic aromatic hydrocarbons. Cancer Res. 1980 Jun;40(6):1981–1984. [PubMed] [Google Scholar]
  22. Slaga T. J., Huberman E., DiGiovanni J., Gleason G., Harvey R. G. The importance of the "bay region" diol-epoxide in 7,12-dimethylbenz[a]anthracene skin tumor initiation and mutagenesis. Cancer Lett. 1979 Apr;6(4-5):213–220. doi: 10.1016/s0304-3835(79)80036-1. [DOI] [PubMed] [Google Scholar]
  23. Slaga T. J., Huberman E., Selkirk J. K., Harvey R. G., Bracken W. M. Carcinogenicity and mutagenicity of benz(a)anthracene diols and diol-epoxides. Cancer Res. 1978 Jun;38(6):1699–1704. [PubMed] [Google Scholar]
  24. Slaga T. J., Jecker L., Bracken W. M., Weeks C. E. The effects of weak or non-carcinogenic polycyclic hydrocarbons on 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene skin tumor-initiation. Cancer Lett. 1979 Jun;7(1):51–59. doi: 10.1016/s0304-3835(79)80076-2. [DOI] [PubMed] [Google Scholar]
  25. Slaga T. J., Klein-Szanto A. J., Triplett L. L., Yotti L. P., Trosko K. E. Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science. 1981 Aug 28;213(4511):1023–1025. doi: 10.1126/science.6791284. [DOI] [PubMed] [Google Scholar]
  26. Slaga T. J. Overview of tumor promotion in animals. Environ Health Perspect. 1983 Apr;50:3–14. doi: 10.1289/ehp.83503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wood A. W., Levin W., Chang R. L., Conney A. H., Slaga T. J., O'Malley R. F., Newman M. S., Buhler D. R., Jerina D. M. Mouse skin tumor-initiating activity of 5-, 7-, and 12-methyl- and fluorine-substituted benz[a]anthracenes. J Natl Cancer Inst. 1982 Sep;69(3):725–728. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES